Chief Executive Officer

21 May 2022

Chief Executive Officer

ALZEVIT Study – RCB No.: 2026-A00246-45

Decentralised national digital cohort for APOE genotyping and longitudinal characterisation of APOE ε4/ε4 homozygote trajectories, with a view to developing strategies for Alzheimer's disease.

Quick Contact

If you have any questions or need assistance, please do not hesitate to contact our team.

Send us an email :

Alzevit@firalis.com

+33 (0) 389 911 320

Chief Executive Officer

Chief Executive Officer

ALZEVIT

Resources

Useful links

Quick Contact